Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
about
In vitro activity of PD 127,391, an enhanced-spectrum quinoloneResistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.Purification of Citrobacter freundii DNA gyrase and inhibition by quinolonesSusceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors.Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.Construction and use of halobacterial shuttle vectors and further studies on Haloferax DNA gyrase.Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acidUse of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.Linkage map of Escherichia coli K-12, edition 6Quinolone antimicrobial agents: adverse effects and bacterial resistance.Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteinsDNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliClinical isolate of Citrobacter freundii highly resistant to new quinolones.Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.Quinolone-resistant mutations of the gyrA gene of Escherichia coli.Two-dimensional crystallization of DNA gyrase B subunit on specifically designed lipid monolayers.[Mechanism of action of quinolones].Mutational resistance to 4-quinolone antibacterial agents.
P2860
Q28361070-CB04EE92-AB2D-4165-8323-D0DEA69BD122Q33742745-ADC4D10C-ADA1-4A4C-8EFC-7E565040D8E9Q35244676-6AFC179E-9229-42C5-9218-07F0BB350AF1Q35289324-D5123757-4452-4319-82FD-DA2A48F53A44Q35572772-796C239D-0D49-4653-85AF-333944E690D7Q35640867-7EF14F76-AAA7-4670-90F6-501C98697F30Q35718618-779ADF7B-AEC0-4F46-973E-72A841F4AB13Q35811107-05BEE7B3-22D9-4E88-8327-C809517C91BCQ36147119-996E90BF-3782-4212-A6D9-62577CB4E7EBQ36753126-636E4BEB-3DCC-44DE-BE8F-C355B508948FQ36755663-A9B458CA-473D-436D-8BF5-34FE23FA59BFQ37066767-D331BE4C-C41F-427B-AD6E-4BCF79090D77Q38322827-A2C8B415-458B-4B8C-96B9-F6EEA9E58E8AQ39472105-C0941DCF-C8BE-47EA-80E8-E779852E47DBQ39780359-E2F89257-35B3-4D47-82E0-380B8658C013Q39816339-E068EDF6-E5A5-4CEB-8E5E-9FFE0F24D51EQ39818366-30BC3913-913E-486D-821E-17BFEC6C68A5Q39827996-D549B5B8-DEC0-453D-9FE2-3DDF9FD6F5BDQ39835001-5B98A0C2-AD94-4D22-A214-0E50C070EED0Q39851366-28401A76-BAC8-45EA-97C2-FC79FD6885B6Q39971230-9F6E0B81-25D8-4430-9CE7-9FF323C3338AQ42115677-31C139C4-A52B-4DA0-9AAE-534AE972CEE1Q48332361-B3605639-5F54-495C-8626-3FB78AE14297Q54425353-A9EA185B-9678-4102-B3E5-C819332D5919Q54439320-7F2F9F42-6D6E-4BD4-A7F9-ADF084D6732CQ54471095-84CE833F-2D7A-4253-A140-BC3275542161
P2860
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
@ast
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
@en
type
label
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
@ast
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
@en
prefLabel
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
@ast
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
@en
P2093
P2860
P356
P1476
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
@en
P2093
P2860
P304
P356
10.1128/AAC.14.2.240
P407
P577
1978-08-01T00:00:00Z